Integra LifeSciences Holdings Corporation (IART): Price and Financial Metrics

Integra LifeSciences Holdings Corporation (IART): $38.45

-0.03 (-0.08%)

POWR Rating

Component Grades













IART Price/Volume Stats

Current price $38.45 52-week high $62.99
Prev. close $38.48 52-week low $37.90
Day low $37.90 Volume 971,200
Day high $39.11 Avg. volume 579,110
50-day MA $53.24 Dividend yield N/A
200-day MA $52.53 Market Cap 3.15B

IART Stock Price Chart Interactive Chart >


  • Value is the dimension where IART ranks best; there it ranks ahead of 85.27% of US stocks.
  • The strongest trend for IART is in Growth, which has been heading down over the past 179 days.
  • IART ranks lowest in Sentiment; there it ranks in the 13th percentile.

IART Stock Summary

  • IART's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 237.05 -- higher than 89.17% of US-listed equities with positive expected earnings growth.
  • INTEGRA LIFESCIENCES HOLDINGS CORP's stock had its IPO on August 16, 1995, making it an older stock than 75.26% of US equities in our set.
  • INTEGRA LIFESCIENCES HOLDINGS CORP's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 8.12%, greater than the shareholder yield of 79.42% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to INTEGRA LIFESCIENCES HOLDINGS CORP, a group of peers worth examining would be SSD, HUN, CW, PLPC, and BRC.
  • IART's SEC filings can be seen here. And to visit INTEGRA LIFESCIENCES HOLDINGS CORP's official web site, go to

IART Valuation Summary

  • In comparison to the median Healthcare stock, IART's price/earnings ratio is 19.92% lower, now standing at 19.3.
  • Over the past 243 months, IART's price/sales ratio has gone down 3.8.

Below are key valuation metrics over time for IART.

Stock Date P/S P/B P/E EV/EBIT
IART 2023-05-23 2.1 2.0 19.3 18.2
IART 2023-05-22 2.7 2.5 24.2 21.5
IART 2023-05-19 2.6 2.4 23.7 21.2
IART 2023-05-18 2.6 2.4 23.7 21.1
IART 2023-05-17 2.6 2.4 23.7 21.1
IART 2023-05-16 2.6 2.4 23.3 20.9

IART Growth Metrics

    Its 2 year price growth rate is now at 21.32%.
  • The 5 year price growth rate now stands at 11.72%.
  • Its year over year revenue growth rate is now at 13.17%.
Over the past 33 months, IART's revenue has gone up $47,611,000.

The table below shows IART's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,565.168 248.412 172.988
2022-06-30 1,566.838 262.878 166.302
2022-03-31 1,559.015 287.69 156.582
2021-12-31 1,542.448 312.427 169.075
2021-09-30 1,525.571 323.412 216.435
2021-06-30 1,508.942 310.272 205.543

IART's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IART has a Quality Grade of C, ranking ahead of 70.12% of graded US stocks.
  • IART's asset turnover comes in at 0.411 -- ranking 114th of 186 Medical Equipment stocks.
  • XENT, ALGN, and CODX are the stocks whose asset turnover ratios are most correlated with IART.

The table below shows IART's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.411 0.614 0.104
2021-06-30 0.416 0.616 0.103
2021-03-31 0.388 0.613 0.086
2020-12-31 0.395 0.620 0.065
2020-09-30 0.406 0.620 0.060
2020-06-30 0.411 0.617 0.030

IART Price Target

For more insight on analysts targets of IART, see our IART price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $77.70 Average Broker Recommendation 1.75 (Moderate Buy)

Integra LifeSciences Holdings Corporation (IART) Company Bio

Integra LifeSciences develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neuro-surgery; U.S. Extremities; U.S. Instruments; U.S. Spine and Other; and International. The company was founded in 1989 and is based in Plainsboro, New Jersey.

IART Latest News Stream

Event/Time News Detail
Loading, please wait...

IART Latest Social Stream

Loading social stream, please wait...

View Full IART Social Stream

Latest IART News From Around the Web

Below are the latest news stories about INTEGRA LIFESCIENCES HOLDINGS CORP that investors may wish to consider to help them evaluate IART as an investment opportunity.

Wall Street Stalls As Default Deadline Looms

Wall Street is lower this afternoon as the default debate rages on. | May 23, 2023

Integra (IART) Builds Advanced R&D Facility in New Jersey

Integra (IART) opens the Dr. Richard E. Caruso Center of Innovation and Learning in New Jersey.

Yahoo | May 15, 2023

Investors in Integra LifeSciences Holdings (NASDAQ:IART) have unfortunately lost 24% over the last five years

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more...

Yahoo | May 15, 2023

Integra LifeSciences Opens New Center of Innovation and Learning

New facility is dedicated to Dr. Richard E. Caruso, late company founder Dr. Richard E. Caruso Center of Learning and Innovation Integra president and CEO Jan De Witte, Integra chairman Stuart Essig, and Mayor Peter Cantu, with Integra board members and leader cutting the ribbon of the Dr. Richard E. Caruso Center of Innovation and Learning. PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, host

Yahoo | May 11, 2023

Integra LifeSciences To Host Investor Day On May 4, 2023

PRINCETON, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:00 p.m., U.S. eastern time on May 4, 2023 in New York, NY. The event will be hosted by Jan DeWitte, president and chief executive officer, along with members of Integra’s executive leadership team. A live webcast will be available on the Investors section of the Company’s websi

Yahoo | May 3, 2023

Read More 'IART' Stories Here

IART Price Returns

1-mo -30.50%
3-mo -32.73%
6-mo -28.39%
1-year -38.13%
3-year -26.28%
5-year -39.71%
YTD -31.43%
2022 -16.30%
2021 3.19%
2020 11.39%
2019 29.22%
2018 -5.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8239 seconds.